Dolamin P in Dialysis Patients

1. Paracetamol Component - SAFE (with minor caution)

• Paracetamol is the analgesic/antipyretic of first choice in renal failure and dialysis patients.
• It is extensively metabolised by the liver, not the kidney.
• Dose adjustment: Maximum 3 g/24 hours (instead of the usual 4 g). Minimum dosing interval of 6 hours.
• Avoid effervescent/dispersible formulations (high sodium content).
• Dialysis does not significantly remove paracetamol, so no supplemental dosing is needed post-dialysis.

2. Domperidone Component - USE WITH CAUTION

• Domperidone is mostly hepatically eliminated - less than 1% is excreted renally as unchanged drug, so it does not significantly accumulate in renal impairment.
• However, in severe renal impairment, the elimination half-life is prolonged.
• Recommended adjustment in severe renal impairment/dialysis:
  • Reduce dosing frequency to once or twice daily (instead of the standard three times daily).
  • Use the lowest effective dose.
  • Keep total daily dose below 30 mg/day.
• Key concern: Domperidone can prolong the QTc interval in a dose-dependent manner, raising risk of serious arrhythmia (including sudden cardiac death) - dialysis patients are already at elevated cardiovascular risk.
• Obtain a baseline ECG and monitor periodically if continued use is needed.
• Avoid if the patient has other QTc-prolonging drugs (common in dialysis patients: some antibiotics, antifungals, antipsychotics).

3. Practical Recommendation

Clinical decisions should always account for the individual patient's full drug list, cardiac status, and clinical context. Consult a nephrologist or clinical pharmacist when in doubt.

Prescription Review - Dialysis Patient

Drug Identification

⚠️ CRITICAL PROBLEM: Paracetamol Overdose / Duplication

• Dolomin P BD = 500mg x 2 = 1000mg paracetamol/day
• Dolo TID = 650mg x 3 = 1950mg paracetamol/day
• Combined total = 2950mg/day

Recommendation: Rationalize - prescribe ONE paracetamol formulation only. If both are being used for different purposes (e.g., Dolo for fever spikes + Dolomin P for nausea), document clearly and counsel the patient.

Drug-by-Drug Assessment

1. Tab Dolomin P (Paracetamol + Domperidone) BD - ⚠️ USE WITH CAUTION

• Safe in dialysis as the first-choice analgesic/antipyretic
• Max 2-3g/day in ESRD (GFR <10); minimum interval 6 hours
• Avoid effervescent formulations (high sodium)

• Mostly hepatically eliminated; does not significantly accumulate in renal failure
• In severe renal impairment, half-life is prolonged - reduce dosing frequency to once or twice daily (already being given BD - acceptable)
• 20mg/day total dose is within the recommended safe limit (<30mg/day)
• Key risk: QTc prolongation - dialysis patients already have high cardiovascular risk
• Action required: Baseline ECG before or soon after starting; avoid co-prescription of other QTc-prolonging drugs

2. Tab Dolo (Paracetamol 650mg) TID - ⚠️ DUPLICATION (see above)

• Safe drug in dialysis individually
• The combination with Dolomin P creates duplication risk - this needs to be rationalized

3. Tab Onden (Ondansetron) - ✅ SAFE

• Ondansetron is safe in CKD and ESRD - no dose adjustment necessary
• Metabolised primarily by the liver; no significant renal elimination
• Standard dose 4-8mg is appropriate
• Note: Ondansetron also mildly prolongs QTc - combined with domperidone in a dialysis patient, monitor QTc (these two are both being given together, which increases QTc risk)

4. Tab Vertitor 16mg (Betahistine 16mg) - ✅ GENERALLY SAFE

• Used for vertigo/Meniere's syndrome
• Primarily metabolised and excreted renally as inactive metabolites
• Official prescribing information states: no dose adjustment necessary in renal impairment based on post-marketing experience
• No significant QTc concern
• Caution if the patient has peptic ulcer, asthma, or pheochromocytoma

5. Tab Rantac (Ranitidine 150mg) - ⚠️ DOSE REDUCTION REQUIRED

• Ranitidine is significantly renally cleared
• In ESRD (GFR <10 ml/min / dialysis): use only 25% of normal dose
• Normal dose is 150mg BD or 300mg OD
• In dialysis: maximum 150mg once daily (or 75mg BD)
• If prescribed as 150mg BD, this needs to be reduced
• Additional concern: Ranitidine is largely unavailable in many countries due to NDMA contamination recalls; famotidine or pantoprazole are safer alternatives in dialysis patients

Summary Table

Overall Verdict

1. Paracetamol duplication - Dolomin P and Dolo together. Must rationalize to one formulation and counsel patient clearly.
2. Ranitidine dose is likely too high - needs reduction to 25% of standard dose in ESRD/dialysis.
3. QTc monitoring is advisable given both domperidone and ondansetron are being co-prescribed in a high-cardiovascular-risk dialysis patient.

This is a clinical assessment for educational purposes. Always verify with the treating nephrologist and refer to current local formulary guidelines for the specific patient.